Morgan Stanley said in its upgrade of the lab company that it sees more upside in the stock due to the coronavirus.positioned to meaningfully benefit as market shifts to phase II of COVID-19 testing. While shares have outperformed since earnings, we see more room for upside. Our updated 2021 estimates are 12% above consensus. Raising price target to $139 and rating to OW.
"UBS said in its downgrade of the stock that it sees a more balanced risk/reward.has outperformed the SPX by 17% YTD and now largely discounts a scenario where 2021 and beyond returns to a normalized pre-COVID environment. We see risks to this view, particularly within the Medical Device and Pharma segments. Our new Revenue and EBIT estimates for 2021 and 2022 are 11% and 10% below our prior estimates and are now 2%+ below consensus.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
Analysts downgrade several stocks, including Amazon and Caterpillar, as Wall Street's dismal earnings season continuesNew for subscribers: Analysts downgrade several stocks, including Amazon and Caterpillar, as Wall Street's dismal earnings season continues Check out CNBCPro for a free trial. Pro How can Amazon be downgraded when their business is booming right now? Pro mr_jettlife Pro But we have the Fed. Nothing else matters
Fonte: CNBC - 🏆 12. / 72 Leggi di più »